IP Library Granted Patent US 7,205,136
Granted Patent B1
US 7,205,136 · App. 08/447,924 · Granted Apr 17, 2007

Catalytic antibodies

Assignee: Wellstat BioCatalysis, LLC.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,205,136
App. No.
08/447,924
Granted
Apr 17, 2007
Kind
B1
Abstract

A method for increasing the rate of chemical reactions involving the conversion of at least one reactant to at least one product involves contacting the reactant with an appropriate monoclonal antibody under conditions permitting the formation of a complex between the antibody and the reactant. The complexed reactant is converted to the product which is then released from the complex. The monoclonal antibody may employ a cofactor and may be directed to a known substrate of an enzyme. Methods for preparing such monoclonal antibodies are also disclosed.

Claims (16)

1. A monoclonal antibody capable of catalytically increasing the rate of a chemical reaction by more than a hundred-fold wherein at least one reactant is converted to at least one product.

2. Monoclonal antibodies for catalytically increasing the rate of a chemical reaction by more than a hundred-fold wherein at least one reactant is converted to at least one product, said antibodies having been produced by a process comprising the steps of:

(a) producing monoclonal antibodies;

(b) screening said monoclonal antibodies for the ability to catalyze said reaction; and

(c) making a quantity, from said monoclonal antibodies screened in step (b), of monoclonal antibodies which catalyze said reaction.

3. The monoclonal antibody of claim 1 , wherein said catalytic antibody is capable of catalytically increasing the rate of a chemical reaction by more than a thousand-fold.

4. The monoclonal antibody of claim 2 , wherein said catalytic antibodies are capable of catalytically increasing the rate of a chemical reaction by more than a thousand-fold.

5. The monoclonal antibody of claim 1 , wherein said catalytic antibody is capable of catalytically increasing the rate of a chemical reaction by more than ten thousand-fold.

6. The monoclonal antibody of claim 2 , wherein said catalytic antibodies are capable of catalytically increasing the rate of a chemical reaction by more than ten thousand-fold.

7. The catalytic antibody of claim 1 , wherein said chemical reaction is selected from the group consisting of oxidations, reductions, additions, condensations, eliminations, substitutions, cleavages and rearrangements.

8. The catalytic antibodies of claim 2 , wherein said chemical reaction is selected from the group consisting of oxidations, reductions, additions, condensations, eliminations, substitutions, cleavages and rearrangements.

9. The catalytic antibody of claim 1 , wherein said monoclonal antibody has an affinity constant K greater than 1.

10. The catalytic antibody of claim 1 , wherein said monoclonal antibody has an affinity constant K greater than 100.

11. The catalytic antibodies of claim 2 , wherein said monoclonal antibodies have an affinity constant K greater than 1.

12. The catalytic antibodies of claim 2 , wherein said monoclonal antibodies have an affinity constant K greater than 100.

13. The catalytic antibody of claim 1 , wherein said chemical reaction is catalyzed by an enzyme.

Assignments (6)
RELEASE OF SECURITY INTEREST Recorded Jan 19, 2021
From: WHITE OAK GLOBAL ADVISORS, LLC, AS ADMINISTRATIVE AGENT
To: WELLSTAT BIOCATALYSIS, LLC
Reel/Frame 054950/0281 →
SECURITY AGREEMENT Recorded Sep 17, 2013
From: WELLSTAT BIOCATALYSIS, LLC
To: PDL BIOPHARMA, INC.
Reel/Frame 031227/0172 →
SECURITY AGREEMENT Recorded Aug 15, 2013
From: WELLSTAT BIOCATALYSIS, LLC
To: WHITE OAK GLOBAL ADVISORS, LLC, AS ADMINISTRATIVE AGENT
Reel/Frame 031030/0520 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 3, 2010
From: PROTEINIX CORPORATION
To: WELLSTAT BIOCATALYSIS, LLC
Reel/Frame 023892/0180 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 30, 2004
From: IGEN INTERNATIONAL, INC.
To: PROTEINIX, INC.
Reel/Frame 015509/0948 →
MERGER Recorded Aug 14, 1998
From: IGEN, INC.
To: IGEN INTERNATIONAL, INC.
Reel/Frame 009396/0070 →
Continuity (6)
Continuation 0811539100 · Aug 31, 1993
Continuation 0794389200 · Sep 11, 1992
Division 0773012500 · Jul 15, 1991
Division 0741154700 · Sep 22, 1989
Division 0667425300 · Nov 27, 1984
Continuation In Part 0655601600 · Nov 29, 1983